Quantcast
Last updated on April 17, 2014 at 8:45 EDT

Latest Star Scientific Inc. Stories

2012-10-16 11:25:42

GLEN ALLEN, Va., Oct. 16, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: STSI) through its wholly owned subsidiary, Rock Creek Pharmaceuticals Inc., reports that earlier in the week scientists from its research partner, the Roskamp Institute, presented results of its recent research showing that anatabine supplementation significantly reduces central and peripheral inflammation and neurological injury in an animal model of multiple sclerosis (MS). The findings were presented in New...

2012-10-15 11:28:25

GLEN ALLEN, Va., Oct. 15, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: STSI) through its wholly owned subsidiary, Rock Creek Pharmaceuticals Inc., reports that scientists from its research partner, the Roskamp Institute, presented new research yesterday and today indicating that supplementation with anatabine, the active ingredient in the Company's Anatabloc® dietary supplement, has the potential to alleviate the negative consequences of traumatic brain injury (TBI). These...

2012-09-10 06:29:46

GLEN ALLEN, Va., Sept. 10, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: STSI) through its wholly owned subsidiary Rock Creek Pharmaceuticals, Inc. announced today that the Company's new Anatabloc® face cream is now available on the cosmetic portion of the Anatabloc® website (www.anatabloc.com) and in select dermatology practices. (Photo: http://photos.prnewswire.com/prnh/20120910/PH70858 ) (Logo: http://photos.prnewswire.com/prnh/20120301/NE62741LOGO ) Star...

2012-08-23 06:25:34

GLEN ALLEN, Va., Aug. 23, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: STSI), through its wholly owned subsidiary Rock Creek Pharmaceuticals Inc., announced today that the Alzheimer's study of the company's dietary supplement Anatabloc(® )has screened and enrolled its first patient. (Logo: http://photos.prnewswire.com/prnh/20120301/NE62741LOGO ) The Alzheimer's study, entitled, "A Three Month, Multi-Site, Double Blind, Randomized, Placebo-Controlled, Parallel-Group Trial to...

2012-08-09 10:26:04

GLEN ALLEN, Va., Aug. 9, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: STSI) today filed its second-quarter 2012 financial report on Form 10-Q with the Securities and Exchange Commission. The Company reported net sales totaling $1.6 million for the three months ending June 30, 2012, compared with net sales of $0.3 million for the same period in 2011. Net sales for the six months ending June 30, 2012, totaled $2.76 million compared with $0.4 million for the same period in 2011. The...

2012-08-06 06:24:07

GLEN ALLEN, Va., Aug. 6, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: CIGX) today announced that the Company will change its NASDAQ trading symbol from CIGX to STSI, effective as of the opening of trading on Tuesday, August 7, 2012. This change is appropriate and timely as the Company approaches the third quarter market entry of its line extension of an Anatabloc® cream facial product, and given the positive response to its Anatabloc® products for anti-inflammatory support....

2012-07-31 06:23:21

GLEN ALLEN, Va., July 31, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: CIGX) is proud to congratulate Anatabloc® Brand Ambassador Fred Couples on his victory at the 2012 Senior British Open in Turnberry, Scotland. In an exciting finish on Sunday, Couples sunk a 25-foot putt and made consecutive birdies on the last two holes to win the tournament by two strokes. Sunday's win marked the first individual victory in Britain for the 52-year-old veteran of the PGA Tour, and his second...

2012-07-18 06:28:08

GLEN ALLEN, Va., July 18, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: CIGX) today announced plans for the production and sale of its new Anatabloc® face cream. The company anticipates a launch of the product during the third quarter of this year. (Logo: http://photos.prnewswire.com/prnh/20120301/NE62741LOGO ) The Anatabloc® face cream is based upon the company's prior work with anatabine and its anatabine citrate formulation. Anatabine is an alkaloid found in...

2012-07-10 06:26:47

GLEN ALLEN, Va., July 10, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: CIGX) announced that the U.S. Patent & Trademark Office (USPTO) has issued a Notice of Allowance for claims covering a product formulation that, among other uses, assists in weight loss and also the reduction of tobacco use. Application No. 12/826,985, entitled "Nutritional Product Containing Anatabine and Yerba Mate," describes and claims compositions containing a combination of anatabine and yerba mate, as...

2012-06-27 06:25:17

GLEN ALLEN, Va., June 27, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: CIGX) announced today that the results of a successful animal study supporting the potential thyroid benefit of nutritional supplementation with Rock Creek Pharmaceuticals' anatabine supplement, Anatabloc®, were presented on Tuesday, June 26, in Houston, Texas, at ENDO 2012, the annual international meeting of the Endocrine Society. (Logo: http://photos.prnewswire.com/prnh/20120301/NE62741LOGO ) The...